Zhengye Biotechnology Holding Limited (ZYBT)

NASDAQ: ZYBT · Real-Time Price · USD

0.7134

-0.0477 (-6.27%)

At close: Jun 26, 2026, 4:00 PM EDT

0.7700

+0.0566 (7.93%)

After-hours: Jun 26, 2026, 6:39 PM EDT

ZYBT Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	116.36	186.36	211.65	260.27	214.07
Revenue Growth (YoY)	-37.56%	-11.95%	-18.68%	21.58%	-
Cost of Revenue	92.49	95.06	94.14	112.39	88.67
Gross Profit	23.87	91.3	117.51	147.88	125.39
Selling, General & Admin	74.92	63.84	64.34	58.89	58.19
Research & Development	18.01	12.79	11.9	13.42	11.37
Other Operating Expenses	1.44	-1.78	-3.71	9.74	3.45
Total Operating Expenses	94.38	74.86	72.52	82.05	73.01
Operating Income	-70.51	16.44	44.99	65.83	52.38
Interest Income	0.1	0.23	0.31	0.11	0.11
Interest Expense	-3.4	-4.04	-4.42	-2.84	-1.05
Other Non-Operating Income (Expense)	1.94	1.77	2.89	0.81	1.62
Total Non-Operating Income (Expense)	-1.37	-2.05	-1.22	-1.92	0.68
Pretax Income	-71.87	14.39	43.76	63.91	53.07
Provision for Income Taxes	11.1	0.92	6.25	8.17	6.6
Net Income	-82.97	13.47	37.51	55.74	46.47
Net Income to Common	-69.78	11.31	31.46	46.74	46.47
Net Income Growth	-	-64.04%	-32.69%	0.58%	-
Shares Outstanding (Basic)	47	46	46	46	46
Shares Outstanding (Diluted)	47	46	46	46	46
Shares Change (YoY)	3.69%	-	-	-	-
EPS (Basic)	-1.47	0.25	0.69	1.02	1.02
EPS (Diluted)	-1.47	0.25	0.69	1.02	1.02
EPS Growth	-	-63.77%	-32.35%	0.25%	-
Free Cash Flow	12.33	27.46	40.79	-9.99	12.75
Free Cash Flow Growth	-55.12%	-32.68%	-	-	-
Free Cash Flow Per Share	0.26	0.60	0.89	-0.22	0.28
Gross Margin	20.51%	48.99%	55.52%	56.82%	58.58%
Operating Margin	-60.59%	8.82%	21.25%	25.29%	24.47%
Profit Margin	-71.30%	7.23%	17.72%	21.42%	21.71%
FCF Margin	10.59%	14.73%	19.27%	-3.84%	5.95%
EBITDA	-44.62	40.6	68.9	84.63	68.4
EBITDA Margin	-38.35%	21.79%	32.55%	32.52%	31.95%
EBIT	-70.51	16.44	44.99	65.83	52.38
EBIT Margin	-60.59%	8.82%	21.25%	25.29%	24.47%
Effective Tax Rate	-15.44%	6.42%	14.29%	12.79%	12.44%

SEC Filings: 10-K · 10-Q